JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 15, Issue 4 (2023)
Iran J War Public Health 2023, 15(4): 361-367 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/10/12 | Accepted: 2023/11/11 | Published: 2023/11/26
Received: 2023/10/12 | Accepted: 2023/11/11 | Published: 2023/11/26
How to cite this article
Ghafil F, Hassan E, Aziz N, Salim M, Majeed S, Rasheed S et al . Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia. Iran J War Public Health 2023; 15 (4) :361-367
URL: http://ijwph.ir/article-1-1405-en.html
URL: http://ijwph.ir/article-1-1405-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia
Authors
F.A. Ghafil1, E.S. Hassan *1, N.D. Aziz2, M.M. Salim3, S.A. Majeed1, S.M.H. Rasheed4, H.W. Mardan5
1- Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq
2- Department of Clinical Pharmacy, Collage of Pharmacy, University of Kerbala, Kerbala, Iraq
3- Department of Clinical Pathology, Faculty of Medicine, University of Kufa, Najaf, Iraq
4- Department of Clinical Microbiology, Faculty of Medicine, University of Kufa, Najaf, Iraq
5- Middle Euphrates Center of Neurosciences, Al-Sadder Teaching Hospital, Al-Najaf Al-Ashraf Health Directorate, Najaf, Iraq
2- Department of Clinical Pharmacy, Collage of Pharmacy, University of Kerbala, Kerbala, Iraq
3- Department of Clinical Pathology, Faculty of Medicine, University of Kufa, Najaf, Iraq
4- Department of Clinical Microbiology, Faculty of Medicine, University of Kufa, Najaf, Iraq
5- Middle Euphrates Center of Neurosciences, Al-Sadder Teaching Hospital, Al-Najaf Al-Ashraf Health Directorate, Najaf, Iraq
Abstract (944 Views)
Aims: The study aimed to assess the cardioprotective potential of celastrol against cardiac injury induced by sepsis via amelioration of IL6, TNF, TLR4, IL10, F2-isoprostane, cardiac troponin, and CK-MB, as well as at histological level.
Materials & Methods: Twenty-four Swiss albino mice aged between 6 and 8 weeks, weighted between 20 and 30g, were included and were randomly divided into four groups; Sham, Sepsis (laparotomy with CLP), Vehicle (treated with the equivalent volume of DMSO), and celastrol (treated with 2mg/kg IP 1hr before CLP) groups. By spectrophotometric assay, blood samples were then aspirated for cardiac troponin and CK-MB assessment. Part of the cardiac tissue was used to assess the levels of TNFα, IL6, IL10, F2-Isoprostane, and TLR4 by ELISA method; another part was used to assess the degree of cardiac tissue damage by histopathological analysis.
Findings: Significant cardiac damage was noticed in the sepsis group (p≤0.05) as compared with the sham group, manifested by a significant elevation in inflammatory markers (TNFα, IL6, TLR4) and oxidative stress marker (F2-Isoprostane) as well as cardiac troponin and CK-MB, with a significant reduction in IL10. Pretreatment with celastrol resulted in a significant reduction in TNF, IL6, TLR4, F2-Isoprostane, troponin, and CK-MB with significant elevation in IL10 compared to the sepsis group. In the same manner, significant histological damage was encountered in the sepsis group compared to the sham group, while the celastrol-treated group exhibited minor histological damage compared to the sepsis group.
Conclusion: Celastrol has cardio-protective effects against cardiac injury induced by endotoxemia.
Materials & Methods: Twenty-four Swiss albino mice aged between 6 and 8 weeks, weighted between 20 and 30g, were included and were randomly divided into four groups; Sham, Sepsis (laparotomy with CLP), Vehicle (treated with the equivalent volume of DMSO), and celastrol (treated with 2mg/kg IP 1hr before CLP) groups. By spectrophotometric assay, blood samples were then aspirated for cardiac troponin and CK-MB assessment. Part of the cardiac tissue was used to assess the levels of TNFα, IL6, IL10, F2-Isoprostane, and TLR4 by ELISA method; another part was used to assess the degree of cardiac tissue damage by histopathological analysis.
Findings: Significant cardiac damage was noticed in the sepsis group (p≤0.05) as compared with the sham group, manifested by a significant elevation in inflammatory markers (TNFα, IL6, TLR4) and oxidative stress marker (F2-Isoprostane) as well as cardiac troponin and CK-MB, with a significant reduction in IL10. Pretreatment with celastrol resulted in a significant reduction in TNF, IL6, TLR4, F2-Isoprostane, troponin, and CK-MB with significant elevation in IL10 compared to the sepsis group. In the same manner, significant histological damage was encountered in the sepsis group compared to the sham group, while the celastrol-treated group exhibited minor histological damage compared to the sepsis group.
Conclusion: Celastrol has cardio-protective effects against cardiac injury induced by endotoxemia.
References
1. Jawad AS, Hassan ES, Mohammad AR. Protective effect of empagliflozin from acute renal injury during endotoxemia in mice model. Lat Am J Pharm. 2022;41(2):463-71. [Link]
2. Hamza RT, Majeed SA, Ghafil FA, Hassan, E. S. Hadi NR. Nephroprotective effect of melatonin in sepsis induces renal injury : CLP mice model. Lat Am J Pharm. 2022;41(3):589-96. [Link]
3. Abd Uljaleel AQ, Hassan ES, Mohammad AR, Hadi NR. Protective effect of dulaglutide on lung injury in endotoxemia mouse model. Iran J War Public Health 2023;15(1):35-42. [Link]
4. Ghafil FA, Majeed SA, Qassam H, Mardan HW, Hadi NR. Nephroprotective effect of gamma-secretase inhibitor on sepsis- induced renal injury in mouse model of clp. Wiad Lek. 2023;76(1):122-30. [Link] [DOI:10.36740/WLek202301117]
5. Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y, et al. Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One. 2013;8(6):e65477. [Link] [DOI:10.1371/journal.pone.0065477]
6. Garg N, Soni KD, Aggarwal R. Unstable cardiac injury complicated with septic shock-a challenge. Burns Trauma. 2016:4:11. [Link] [DOI:10.1186/s41038-016-0035-y]
7. Mohammed Hussain Hadi S, Majeed S, Ghafil FA, Altoraihi K, Hadi NR. Effect of sulforaphane on cardiac injury induced by sepsis in a mouse model : Role of toll-like receptor 4. J Med Life. 2023;16(7):1120-6. [Link] [DOI:10.25122/jml-2023-0015]
8. Abdul Kadhim SA, Ghafil FA, Majeed SA, Hadi NR. Nephroprotective effects of curcumin against cyclosporine a-induced nephrotoxicity in rat model. Wiad Lek. 2021;74(12):3135-46. [Link] [DOI:10.36740/WLek202112103]
9. Abd Uljaleel A, Hassan E. Protective effect of ertugliflozin against acute lung injury caused by endotoxemia model in mice. Iran J War Public Health. 2023;15(1):67-75. [Link]
10. Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, et al. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: A review of the literature. Crit Care. 2018;22(1):112. [Link] [DOI:10.1186/s13054-018-2043-8]
11. Smart L, Bosio E, Macdonald SPJ, Dull R, Fatovich DM, Neil C, et al. Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan. J Crit Care. 2018;47:93-8. [Link] [DOI:10.1016/j.jcrc.2018.06.015]
12. Vasques-Nóvoa F, Laundos TL, Madureira A, Bettencourt N, Nunes JPL, Carneiro F, et al. Myocardial edema: An overlooked mechanism of septic cardiomyopathy?. Shock. 2020;53(5):616-9. [Link] [DOI:10.1097/SHK.0000000000001395]
13. Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, et ak. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7(5):e2234. [Link] [DOI:10.1038/cddis.2016.140]
14. Ghazi A, Majeed SA, Metib NJ, Abood SH, Alaqouli H, Hadi NR. Ibudilast ameliorates acute pancreatitis through downregulation of interleukin-1 beta and lipase Enzyme. Asian J Pharm. 2020;14(1):9-11. [Link]
15. Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A. 2006;103:19794-9. [Link] [DOI:10.1073/pnas.0609671104]
16. Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol. 2014;171(13):3115-31. [Link] [DOI:10.1111/bph.12677]
17. Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169-93. [Link] [DOI:10.1038/s41569-020-00435-x]
18. Blangy-Letheule A, Persello A, Rozec B, Waard M De, Lauzier B. New approaches to identify sepsis biomarkers: The importance of model and sample source for mass spectrometry. Oxid Med Cell Longev. 2020;2020:6681073. [Link] [DOI:10.1155/2020/6681073]
19. Hadi SMH, Majeed S, Ghafil FAS, Altoraihi K, Hadi NR. Xanthohumol ameliorates cardiac injury induced by sepsis in a mice model: role of toll-like receptor 4. J Med Life. 2023;16(7):1105-10. [Link] [DOI:10.25122/jml-2023-0016]
20. Mohammad AR, Hadi AR, Hassan ES. Potential protective effect of ibrutinib from acute brain injury during endotoxemia in mice. Lat Am J Pharm. 2022;41 (2):472-80. [Link]
21. Hussein SN, Majeed SA, Ghafil FA, Hassan ES, Abdulkadim AH, Ghazi A, et al. Nephroprotective effect of Celastrol in an experimental model of Endotoxemia. Bulletin of national institute of health. 2022;140(6):2865-74.
22. Venkatesha SH, Dudics S, Astry B, Moudgil KD. Control of autoimmune inflammation by celastrol, a natural triterpenoid. Pathog Dis. 2016;74(6):ftw059. [Link] [DOI:10.1093/femspd/ftw059]
23. Kurosawa R, Satoh K, Nakata T, Shindo T, Kikuchi N, Satoh T, et al. Identification of celastrol as a novel therapeutic agent for pulmonary arterial hypertension and right ventricular failure through suppression of Bsg (Basigin)/CyPA (Cyclophilin A). Arterioscler Thromb Vasc Biol. 2021;41(3):1205-17. [Link] [DOI:10.1161/ATVBAHA.120.315731]
24. Tao Z, Xiao Q, Che X, Zhang H, Geng N, Shao Q. Regulating mitochondrial homeostasis and inhibiting inflammatory responses through Celastrol. Ann Transl Med. 2022;10(7):400. [Link] [DOI:10.21037/atm-21-7015]
25. Der Sarkissian S, Cailhier JF, Borie M, Stevens LM, Gaboury L, Mansour S, et al. Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1. Br J Pharmacol. 2014;171(23):5265-79. [Link] [DOI:10.1111/bph.12838]
26. Hassan ES, Jawad AS, Mohammad AR. Protective effect of liraglutide from acute renal injury during endotoxemia in mice mode. Lat Am J Pharm. 2022;41(2):428-36. [Link]
27. Yu X, Meng X, Xu M, Zhang X, Zhang Y, Ding G, et al. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine. 2018;36:266-80. [Link] [DOI:10.1016/j.ebiom.2018.09.031]
28. Hussein SN, Majeed SA, Ghafil FA, Hassan ES, Hadi NR. Toll-like receptors 4 antagonist, Ibudilast, ameliorates acute renal impairment induced by sepsis in an experimental model. BNJHS. 2022;140(7):2900-9. [Link]
29. Lackner I, Weber B, Chakraborty S, Braumüller S, Huber-Lang M, Gebhard F, et al. Toll-like receptor-mediated cardiac injury during experimental sepsis. Mediators Inflamm. 2020;2020:6051983. [Link] [DOI:10.1155/2020/6051983]
30. Sang Z, Zhang P, Wei Y, Dong S. MiR-214-3p attenuates sepsis-induced myocardial dysfunction in mice by inhibiting autophagy through PTEN/AKT/mTOR Pathway. Biomed Res Int. 2020;2020:1409038.. [Link] [DOI:10.1155/2020/1409038]
31. Liu Z, Zeng Z, Wu C, Liu H. Tropisetron inhibits sepsis by repressing hyper-inflammation and regulating the cardiac action potential in rat models. Biomed Pharmacother. 2019;110:380-8. [Link] [DOI:10.1016/j.biopha.2018.11.142]
32. Mohammad AR, Shnaien AA, Alabsawy SK, Hassan ES. Protective effect of ipragliflozin in acute brain injury induced by endotoxemia in mice. Iran J War Public Health 2023;15(3):1001-8. [Link] [DOI:10.58209/ijwph.15.3.225]
33. Shnaien A, Mohammad A, Hassan E. Neuroprotective effects of semaglutide in endotoxemia mouse model. Iran J War Public Health 2023;15(2):199-205. [Link] [DOI:10.58209/ijwph.15.3.225]
34. Gao S, Li H, Xie H, Wu S, Yuan Y, Chu L, et al. Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model. Parasit Vectors. 2020;13(1):260. [Link] [DOI:10.1186/s13071-020-04104-3]
35. Zhao J, Sun Y, Shi P, Dong JN, Zuo LG, Wang HG, et al. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy. Int Immunopharmacol. 2015;26(1):221-8. [Link] [DOI:10.1016/j.intimp.2015.03.033]
36. Alnfakh ZA, Al-Mudhafar DH, Al-Nafakh RT, Jasim AE, Hadi NR. The anti-inflammatory and antioxidant effects of Montelukast on lung sepsis in adult mice. J Med Life. 2022;15(6):819-27. [Link] [DOI:10.25122/jml-2021-0269]
37. Zeng N, Jian Z, Zhu W, Xu J, Fan Y, Xiao F. KLF13 overexpression protects sepsis-induced myocardial injury and LPS-induced inflammation and apoptosis. Int J Exp Pathol. 2023;104(1):23-32. [Link] [DOI:10.1111/iep.12459]
38. Sameer AS, Nissar S. Toll-Like Receptors (TLRs): Structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility. Biomed Res Int. 2021;2021:1157023. [Link] [DOI:10.1155/2021/1157023]
39. Afrazi A, Branca MF, Sodhi CP, Good M, Yamaguchi Y, Egan CE, et al. Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem. 2014;289(14):9584-99. [Link] [DOI:10.1074/jbc.M113.526517]
40. Li Z, Zhang J, Duan X, Zhao G, Zhang M. Celastrol: A promising agent fighting against cardiovascular diseases. Antioxidants. 2022;11(8):1597. [Link] [DOI:10.3390/antiox11081597]
41. Li G, Liu D, Zhang Y, Qian Y, Zhang H, Guo S, et al. Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression. PLoS One. 2013;8(7):e68905. [Link] [DOI:10.1371/journal.pone.0068905]
42. Zigam QA, Al-Zubaidy AA, Sami Z, Abbas WJ. The effects of levosimendan against sepsis-induced cardiotoxicity in mice model. J Med Chem Sci. 2023;6(3):634-44. [Link]
43. Fan J, Ren M, Chen W, Wang H, He Y. Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats. Int Immunopharmacol. 2023;121:110511. [Link] [DOI:10.1016/j.intimp.2023.110511]
44. Zhao X, Huang B, Zhang J, Xiang W, Zhu N. Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE/Ang II/AGTR1 signaling pathway. Diabetol Metab Syndr. 2023;15(1):1-12. [Link] [DOI:10.1186/s13098-023-01159-x]